TUSC3: a novel tumour suppressor gene and its functional implications. Issue 9 (8th March 2017)

• Record Type: Journal Article
• Authors: Yu, Xinshuang; Zhai, Chunjuan; Fan, Yujun; Zhang, Jiandong; Liang, Ning; Liu, Fengjun; Cao, Lili; Wang, Jia; Du, Juan
• Is Part Of: Journal of cellular and molecular medicine. Volume 21:Issue 9(2017)
• Page Start: 1711
• Page End: 1718
• Publication Date: 2017-03-08
• Subjects: tumour suppressor candidate 3 -- oligosaccharyl transferase -- tumourgenesis -- N‐glycosylation reaction; Cytology; Medicine; Molecular Biology; Cytologie -- Périodiques; Médecine -- Périodiques; Biologie moléculaire -- Périodiques; Cytology -- Periodicals; Medicine -- Periodicals; Molecular biology -- Periodicals; 611.01805
• DOI: 10.1111/jcmm.13128
• Languages: English
• ISSNs: 1582-1838

Abstract

Abstract: The tumour suppressor candidate 3 (TUSC3) gene is located on chromosome region 8p22 and encodes the 34 kD TUSC3 protein, which is a subunit of the oligosaccharyl transferase responsible for the N ‐glycosylation of nascent proteins. Known to be related to autosomal recessive mental retardation for several years, TUSC3 has only recently been identified as a potential tumour suppressor gene. Based on the structure and function of TUSC3, specific mechanisms in various diseases have been investigated. Several studies have demonstrated that TUSC3 is an Mg 2+ ‐transporter involved in magnesium transport and homeostasis, which is important for learning and memory, embryonic development and testis maturation. Moreover, dysfunction or deletion of TUSC3 exerts its oncological effects as a modulator by inhibiting glycosylation efficiency and consequently inducing endoplasmic reticulum stress and malignant cell transformation. In this study, we summarize the advances in the studies of TUSC3 and comment on the potential roles of TUSC3 in diagnosis and treatment of TUSC3‐related diseases, especially cancer.